Symbiotics
Daniel Schriber is an experienced professional in impact investment and humanitarian operations, currently serving as the Head of Investments at Symbiotics since January 2006. Under Daniel's leadership, the investment team expanded to 25 members, achieving over USD 1 billion in annual investment origination and a portfolio nearing USD 3 billion with a low default rate. Daniel's previous roles at Symbiotics include Director of Research & Advisory and Regional Manager for EMEA. Prior to Symbiotics, Daniel held various significant positions at the International Committee of the Red Cross, including Deputy Head of Operations for Eastern Europe, and has extensive experience in managing large teams and budgets across different regions. Daniel holds multiple degrees, including a Master’s in International Relations and an Executive MBA in Finance and Management.
Symbiotics
Symbiotics is the leading market access platform for impact investing, dedicated to private markets in emerging and frontier economies. The group offers investment, asset management and capacity building services. Since 2005, we have originated over 7,300 investments representing more than USD 9.2 billion for 570 companies in 95 countries. We manage an aggregate portfolio of USD 2.9 billion spread across 23 funds and mandates. Our portfolio companies have also benefited from over 145 technical assistance projects worth more than USD 18 million.